Appointment of Mr. P.N. Rao as General Manager - Quality.
ANUHPHR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Anuh Pharma Limited's Board meeting on 20th May 2026 approved multiple items including audited financial results for FY2026 showing total revenue of Rs. 77,601.30 lakhs and profit after tax of Rs. 4,104.61 lakhs. The Board recommended a dividend of Rs. 1.50 per equity share (30% payout) subject to shareholder approval at the AGM on 12th August 2026. Key appointments include Mr. P.N. Rao as General Manager - Quality (effective 1st June 2026) who brings 23+ years of pharmaceutical quality experience. The company also appointed new internal auditors RMJ & Associates LLP and re-appointed cost auditor Ankit Kishor Chande. Additionally, 9 shareholders holding 0.95% stake have sought re-classification from Promoter Group to Public category. The share capital doubled to Rs. 5,011.20 lakhs following a 1:1 bonus issue approved in September 2025.
The appointment of an experienced quality leader and approval of strong financials with dividend payout signals operational stability. The promoter re-classification requests are minor (under 1% total) and unlikely to impact control structure.